You can find the annual or quarterly income statement of Evommune Inc here for insights into the performance and operational efficiency of Evommune Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

Total revenue

--0.00

Revenue

--0.00

Operating expenses

--23.95M

--29.72M

R&D expenses

--17.32M

--20.40M

Depreciation, depletion, and amortization

--349.00K

----

Operating profit

---23.95M

---29.72M

Net non-operating interest income (expenses)

Non-operating interest income

--2.28M

----

Special income (expenses)

--0.00

----

Other non-operating income (expenses)

---4.00K

--1.44M

Income before tax

---21.67M

----

Income tax

--0.00

----

Income after tax

---21.67M

----

Net income from continuous operations

---21.67M

---28.27M

Net income attributable to controlling interests

---21.67M

---28.27M

Net income attributable to common shareholders

---21.67M

---28.27M

Basic earnings per share

---0.64

----

Diluted earnings per share

---0.64

----

Dividend per share

--0.00

----

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

